Combinatorial Chemistry & High Throughput Screening
Title:Viral Evolution will Automatically Resolve COVID-19 Pandemic
Volume: 23 Issue: 8
Author(s): Deepak Sharma*
Affiliation:
- Indian Institute of Technology Roorkee Roorkee 247667,India
Export Options
About this article
Cite this article as:
Sharma Deepak *, Viral Evolution will Automatically Resolve COVID-19 Pandemic, Combinatorial Chemistry & High Throughput Screening 2020; 23 (8) . https://dx.doi.org/10.2174/1386207323666200724150726
DOI https://dx.doi.org/10.2174/1386207323666200724150726 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
24
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial [Hot Topic: Applications of Angiotensin Converting Enzyme Inhibitors and of Angiotensin II Receptor Blockers in Pharmacology and Therapy: An Update (Executive Editor: Agostino Molteni)]
Current Pharmaceutical Design Prevention Knowledge and Its Practice Towards COVID-19 Among General Population of Saudi Arabia: A Gender-based Perspective
Current Pharmaceutical Design Balancing Science and Art in Medicine: COVID-19 and the Necessary Humanistic Shift in Medical Care
Current Women`s Health Reviews Design and In-silico Screening of Peptide Nucleic Acid (PNA) Inspired Novel Pronucleotide Scaffolds Targeting COVID-19
Current Computer-Aided Drug Design Learning from Metabolic Networks: Current Trends and Future Directions for Precision Medicine
Current Medicinal Chemistry Neutralization of SARS-CoV-2 Spike Protein via Natural Compounds: A Multilayered High Throughput Virtual Screening Approach
Current Pharmaceutical Design Information Disclosed in Patent Documents being the Source to Address Emergencies: A Strategy to Achieve Technological Developments Addressing COVID-19
Recent Patents on Biotechnology Nano-Biomaterials as Sensing and Therapeutic Tool to Mitigate Viral Pathogenesis with Special Reference to COVID-19
Current Pharmaceutical Design Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19)
Mini-Reviews in Medicinal Chemistry New Coronavirus Outbreak
Current Pharmaceutical Analysis Covid-19 Susceptibility and Severity Might be Modified by Vitamin D Status: Theoretical and Practical Considerations
Current Respiratory Medicine Reviews Harnessing the Natural Pool of Polyketide and Non-ribosomal Peptide Family: A Route Map towards Novel Drug Development
Current Molecular Pharmacology The pH-Triggered Conversion of the PrP<sup>c</sup> to PrP<sup>sc</sup>
Current Topics in Medicinal Chemistry COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development
Pharmaceutical Nanotechnology Synthesis of Four Heterocyclic Drug Molecules Repurposed for COVID-19
Mini-Reviews in Organic Chemistry Defining Carbohydrate Antigens as HIV Vaccine Candidates
Current Pharmaceutical Design Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients
Current Pharmaceutical Design Chloroquine as Chemoprophylaxis for COVID-19: Will This Work
Infectious Disorders - Drug Targets In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases
Infectious Disorders - Drug Targets Distorted Key Theory and its Implication for Drug Development
Current Proteomics